: 
Heart failure updates By John J V McMurray; Marc A Pfeffer
2003 | 285 Pages | ISBN: 0203488660 | PDF | 2 MB
Content: Anticytokine Therapy: What Went Wrong? Heart Failure Due to Diastolic Dysfunction: Definition, Diagnosis and Treatment Omaptrilat: The Potential of Vasopeptidase Inhibition Angiotensin Receptor Blockers: ELITE, ValHEFT and Where Next? Atrial Fibrillation and Heart Failure: Aetiological, Prognostic and Therapeutic Considerations Endothelin Receptor Antagonists: Will They Join the Therapeutic Armamentarium? Betablockers: Mandatory for All? Aldosterone Receptor Blockade: Is There an Opportunity for Further Blockade in Patients with Heart Failure Treated with Standard Therapy Including an ACE-Inhibitor and a Beta Adrenergic Blocking Agent? Nurse Intervention: Can Our Patients Do Without It? Innovative Surgery: A New Dawn in Heart Failure? The Era of Devices? Biventricular Pacing and ICDs New Treatments for Heart Failure: Successes and Failures Metabolic Co-morbid Conditions in Chronic Heart Failure: Diabetes and Hypercholesterolemia BNP: A Blood Test for the Diagnosis of Heart Failure and Monitoring of Its Treatment? Index
Links are Interchangeable - No Password - Single Extraction